ChoA Pharmaceutical Balance Sheet Health
Financial Health criteria checks 3/6
ChoA Pharmaceutical has a total shareholder equity of ₩32.7B and total debt of ₩22.8B, which brings its debt-to-equity ratio to 69.8%. Its total assets and total liabilities are ₩72.5B and ₩39.9B respectively.
Key information
69.8%
Debt to equity ratio
₩22.80b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩6.17b |
| Equity | ₩32.66b |
| Total liabilities | ₩39.87b |
| Total assets | ₩72.53b |
Recent financial health updates
ChoA Pharmaceutical (KOSDAQ:034940) Is Carrying A Fair Bit Of Debt
Nov 12
Would ChoA Pharmaceutical (KOSDAQ:034940) Be Better Off With Less Debt?
Aug 12ChoA PharmaceuticalLtd (KOSDAQ:034940) Has A Pretty Healthy Balance Sheet
Jan 31
Recent updates
ChoA Pharmaceutical (KOSDAQ:034940) Is Carrying A Fair Bit Of Debt
Nov 12Would ChoA Pharmaceutical (KOSDAQ:034940) Be Better Off With Less Debt?
Aug 12ChoA PharmaceuticalLtd (KOSDAQ:034940) Has A Pretty Healthy Balance Sheet
Jan 31Did You Miss ChoA PharmaceuticalLtd's (KOSDAQ:034940) 36% Share Price Gain?
Dec 09Financial Position Analysis
Short Term Liabilities: A034940's short term assets (₩41.2B) exceed its short term liabilities (₩32.0B).
Long Term Liabilities: A034940's short term assets (₩41.2B) exceed its long term liabilities (₩7.9B).
Debt to Equity History and Analysis
Debt Level: A034940's net debt to equity ratio (50.9%) is considered high.
Reducing Debt: A034940's debt to equity ratio has increased from 32.6% to 69.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A034940 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: A034940 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 37% each year